JP2021523106A5 - - Google Patents

Info

Publication number
JP2021523106A5
JP2021523106A5 JP2020560991A JP2020560991A JP2021523106A5 JP 2021523106 A5 JP2021523106 A5 JP 2021523106A5 JP 2020560991 A JP2020560991 A JP 2020560991A JP 2020560991 A JP2020560991 A JP 2020560991A JP 2021523106 A5 JP2021523106 A5 JP 2021523106A5
Authority
JP
Japan
Prior art keywords
msc
exosomes
stem cell
mesenchymal stem
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020560991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523106A (ja
JP7538044B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/029275 external-priority patent/WO2019217091A1/en
Publication of JP2021523106A publication Critical patent/JP2021523106A/ja
Publication of JP2021523106A5 publication Critical patent/JP2021523106A5/ja
Priority to JP2024033810A priority Critical patent/JP2024138218A/ja
Application granted granted Critical
Publication of JP7538044B2 publication Critical patent/JP7538044B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020560991A 2018-04-30 2019-04-26 間葉系間質細胞エキソソームおよびそれらの使用 Active JP7538044B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024033810A JP2024138218A (ja) 2018-04-30 2024-03-06 間葉系間質細胞エキソソームおよびそれらの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862664696P 2018-04-30 2018-04-30
US62/664,696 2018-04-30
PCT/US2019/029275 WO2019217091A1 (en) 2018-04-30 2019-04-26 Mesenchymal stromal cell exosomes and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024033810A Division JP2024138218A (ja) 2018-04-30 2024-03-06 間葉系間質細胞エキソソームおよびそれらの使用

Publications (3)

Publication Number Publication Date
JP2021523106A JP2021523106A (ja) 2021-09-02
JP2021523106A5 true JP2021523106A5 (cg-RX-API-DMAC7.html) 2022-05-10
JP7538044B2 JP7538044B2 (ja) 2024-08-21

Family

ID=68466806

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020560991A Active JP7538044B2 (ja) 2018-04-30 2019-04-26 間葉系間質細胞エキソソームおよびそれらの使用
JP2024033810A Pending JP2024138218A (ja) 2018-04-30 2024-03-06 間葉系間質細胞エキソソームおよびそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024033810A Pending JP2024138218A (ja) 2018-04-30 2024-03-06 間葉系間質細胞エキソソームおよびそれらの使用

Country Status (6)

Country Link
US (1) US12521418B2 (cg-RX-API-DMAC7.html)
EP (1) EP3810271A4 (cg-RX-API-DMAC7.html)
JP (2) JP7538044B2 (cg-RX-API-DMAC7.html)
CN (1) CN112334190B (cg-RX-API-DMAC7.html)
CA (1) CA3098514A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019217091A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3145493T3 (da) 2014-05-18 2022-10-31 Childrens Medical Center Fremgangsmåder og sammensætninger vedrørende exosomer
EP3801028A4 (en) 2018-05-30 2022-04-13 Direct Biologics LLC A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use
US12569517B2 (en) 2019-02-07 2026-03-10 Direct Biologics, Llc Method for treating osteoarthritis with mesenchymal stem cell exosomes
US12213995B2 (en) 2019-07-18 2025-02-04 Direct Biologics, Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
CN111281889A (zh) * 2020-04-16 2020-06-16 博生众康(厦门)医药生物技术股份有限公司 人脐带间充质干细胞外泌体的用途
KR20230004709A (ko) * 2020-04-22 2023-01-06 다이렉트 바이오로직스 엘엘씨 감염성 질환과 연관된 염증성 병태를 치료하기 위한 방법 및 조성물
CN117363568B (zh) * 2023-12-04 2024-04-09 山东大学 一种脂肪间充质干细胞外泌体及其制备方法与应用
US12502407B2 (en) 2024-04-25 2025-12-23 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US20040214783A1 (en) 2002-05-08 2004-10-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
WO2006110582A1 (en) 2005-04-08 2006-10-19 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
WO2008020815A1 (en) 2006-08-15 2008-02-21 Agency For Science, Technology And Research Mesenchymal stem cell conditioned medium
EP1937801A1 (en) 2005-09-02 2008-07-02 Agency for Science, Technology and Research Method of deriving mesenchymal stem cells
US20090274665A1 (en) 2006-04-27 2009-11-05 Cell Therapy Technologies, Inc. Stem Cells For Treating Lung Diseases
PT2578081E (pt) 2006-10-11 2016-06-17 Massachusetts Inst Technology Composições, métodos e dispositivos para o tratamento de doenças hepáticas
EP1944361A1 (en) 2007-01-11 2008-07-16 INSERM (Institut National de la Santé et de la Recherche Médicale) A method for expanding monocytes
AU2009203638C1 (en) 2008-01-04 2013-07-25 Lydac Neuroscience Limited Microvesicles
EP2254586B1 (en) 2008-02-22 2015-04-08 Agency For Science, Technology And Research (A*star) Mesenchymal stem cell particles
SG177467A1 (en) 2009-07-23 2012-02-28 Agency Science Tech & Res Pre-natal mesenchymal stem cells
WO2011053257A2 (en) 2009-11-02 2011-05-05 Agency For Science, Technology And Research (A*Star) Methods of monitoring cellular states
KR101189655B1 (ko) 2010-06-30 2012-10-11 성균관대학교산학협력단 줄기세포 배양액을 포함하는 폐질환 치료용 조성물
CN101890050B (zh) 2010-07-14 2012-07-04 江苏大学 脐带间质干细胞来源膜性囊泡及其应用
WO2012020308A2 (en) 2010-08-13 2012-02-16 The University Court Of The University Of Glasgow Cellular and molecular therapies
EP2678448A4 (en) 2011-02-22 2014-10-01 Caris Life Sciences Luxembourg Holdings S A R L CIRCULATING BIOMARKERS
US9901600B2 (en) 2011-03-11 2018-02-27 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
JP2014519340A (ja) 2011-06-16 2014-08-14 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． バイオマーカー組成物および方法
ITTO20111183A1 (it) 2011-12-21 2013-06-22 Univ Degli Studi Torino Mezzo condizionato ottenuto da cellule staminali mesenchimali placentari e suo uso nel trattamento terapeutico della preeclampsia
US9427450B2 (en) 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
EP2833893B1 (en) 2012-04-03 2018-08-29 Reneuron Limited Stem cell microparticles
KR101399056B1 (ko) 2012-04-16 2014-05-27 연세대학교 산학협력단 줄기세포-유래 미세소포체를 유효성분으로 포함하는 신경질환 예방 또는 치료용 약제학적 조성물
US20130273011A1 (en) 2012-04-17 2013-10-17 Medistem, Inc. Stem cells and stem cell generated nanoparticles for treatment of inflammatory conditions and acute radiation syndrome
US20150125950A1 (en) 2012-05-18 2015-05-07 Agency For Science, Technology And Research (A*Sta (A*Star) Umbilical cord mesenchymal stem cell exosomes
EP2687219A1 (en) 2012-07-18 2014-01-22 Universität Duisburg-Essen Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
JP2015524849A (ja) 2012-08-15 2015-08-27 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ 神経変性疾患に対するエキソソームに基づく治療法
CN103767985A (zh) 2012-10-22 2014-05-07 吉林省霍普金斯药物研究院有限责任公司 人源血液或间充质干细胞分泌exosome的制备与应用
US20160002597A1 (en) 2013-02-12 2016-01-07 Reneuron Limited Method of producing microparticles
CA2910802A1 (en) 2013-04-12 2014-10-16 Samir El Andaloussi Therapeutic delivery vesicles
JP2016528151A (ja) 2013-08-07 2016-09-15 ピーアイ セラミック ゲーエムベーハー 鉛含有量が低減された圧電セラミック材料
WO2015038075A1 (en) 2013-09-16 2015-03-19 Agency For Science, Technology And Research Method
WO2016043654A1 (en) 2014-09-15 2016-03-24 Agency For Science, Technology And Research Methods of treating graft versus host disease (gvhd) or epidermolysis bullosa (eb) with exosomes
US20180273906A1 (en) * 2014-04-17 2018-09-27 Muhammad Ashraf Microvesicle and stem cell compositions for therapeutic applications
DK3145493T3 (da) 2014-05-18 2022-10-31 Childrens Medical Center Fremgangsmåder og sammensætninger vedrørende exosomer
US10166254B2 (en) 2014-09-19 2019-01-01 Wisconsin Alumni Research Foundation Use of mesenchymal stem cell-educated macrophages to treat and prevent graft versus host disease and radiation-induced injury
AU2017220148A1 (en) * 2016-02-18 2018-07-19 Pluristem Ltd. Methods and compositions for treating cancers and neoplasms
CN105769916B (zh) 2016-04-29 2019-07-23 南京大学 间充质干细胞来源外泌体在制备治疗子痫前期药物或者制剂中的应用
CA3027970A1 (en) 2016-06-17 2017-12-21 United Therapeutics Corporation Extracellular vesicles with enhanced potency
KR101973284B1 (ko) * 2017-01-16 2019-04-29 사회복지법인 삼성생명공익재단 신생아 ｈｉｅ 치료용 조성물
US11760975B2 (en) 2017-03-31 2023-09-19 Wisconsin Alumi Research Foundation Generation of therapeutic cells using extracellular components of target organs
CN111212653A (zh) 2017-08-15 2020-05-29 儿童医学中心公司 经纯化间充质干细胞外排体及其用途
US11499730B2 (en) 2018-02-12 2022-11-15 Wisconsin Alumni Research Foundation LPS priming of stromal cells to generate LPS-specific exosome educated macrophages
CA3099042A1 (en) 2018-05-09 2019-11-14 Children's Medical Center Corporation Mesenchymal stromal cell exosome -treated monocytes and uses thereof
EP3846782A4 (en) 2018-09-05 2022-07-13 Children's Medical Center Corporation Use of mesenchymal stromal cell exosomes in antenatal therapy

Similar Documents

Publication Publication Date Title
JP2021523106A5 (cg-RX-API-DMAC7.html)
JP6327647B2 (ja) 炎症性疾患の予防又は治療用組成物
Zhao et al. Transplantation of cerebral dopamine neurotrophic factor transducted BMSCs in contusion spinal cord injury of rats: promotion of nerve regeneration by alleviating neuroinflammation
JP2021522824A5 (cg-RX-API-DMAC7.html)
JP2020152698A5 (cg-RX-API-DMAC7.html)
KR20150009528A (ko) 불사화 줄기세포 및 그 생산물을 유효 성분으로 하는 의약 조성물 및 의약 제제
Galipeau Mesenchymal stromal cells for graft-versus-host disease: a trilogy
Gordiienko et al. Empty nose syndrome pathogenesis and cell-based biotechnology products as a new option for treatment
CN112826833A (zh) 间充质干细胞在制备新冠肺炎引起的肺损伤修复药物中的应用
Soliman et al. COVID-19 disease treatment: pivotal challenges in the arena of umbilical cord-mesenchymal stem cells (UC-MSCs)
Rostami et al. The role of Dental-derived stem cell-based therapy and their derived extracellular vesicles in post-COVID-19 syndrome-induced tissue damage
CN107661501A (zh) 一种治疗强直性脊柱炎的药物组合物、药物靶点及其应用
Prokopyuk et al. Experience in clinical application of cryopreserved placental derivatives: cells, tissue, membranes, extract, and cord blood serum
JP2021155335A (ja) 変形性関節症の処置および／または予防方法
WO2025208891A1 (zh) 一种使用成纤维细胞抑制炎症反应的方法
KR20220077986A (ko) 불멸화 개줄기세포 또는 이의 엑소좀풍부배양액을 유효성분으로 포함하는 염증성 질환의 예방 또는 치료용 조성물
Chand et al. Stem cell therapy for neuroprotection in the growth-restricted newborn
KR20200114769A (ko) 저선량방사선에 의한 류마티스 관절염 치료 효과
Pawelec et al. Stem cell experiments moves into clinic: new hope for children with bronchopulmonary dysplasia
CN117679493B (zh) 一种通过免疫调控来治疗或预防肌腱病的药物及其应用
Hutchison Report on a case of hemi-hypertrophy, with post-mortem examination
CN119235921B (zh) 一种治疗与脂肪变性相关疾病的细胞治疗药物
Koul et al. Longitudinal Extensive Transverse Myelitis in a Four-Year-Old Boy Liver Transplant Recipient
TW202021610A (zh) 短胜肽用於治療/預防高血壓及其相關疾病之用途
Albert et al. Kawasaki disease complicated by pancreatitis in an adult: 963